Literature DB >> 25745188

The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients.

Winnie W Y Lau1, Rebecca Hannah2, Anthony R Green3, Bertie Göttgens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25745188      PMCID： PMC4471770          DOI： 10.1182/blood-2014-12-618074

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors:  Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

4.  Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.

Authors:  Jan Jacob Schuringa; Kaida Wu; Giovanni Morrone; Malcolm A S Moore
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 5.  Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapy.

Authors:  Florence Pasquier; Xenia Cabagnols; Lise Secardin; Isabelle Plo; William Vainchenker
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-09

6.  Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.

Authors:  Raajit Rampal; Fatima Al-Shahrour; Omar Abdel-Wahab; Jay P Patel; Jean-Philippe Brunel; Craig H Mermel; Adam J Bass; Jennifer Pretz; Jihae Ahn; Todd Hricik; Outi Kilpivaara; Martha Wadleigh; Lambert Busque; D Gary Gilliland; Todd R Golub; Benjamin L Ebert; Ross L Levine
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

Review 7.  Janus kinase deregulation in leukemia and lymphoma.

Authors:  Edwin Chen; Louis M Staudt; Anthony R Green
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

8.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors:  J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

9.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.

Authors:  Edward Y Chen; Christopher M Tan; Yan Kou; Qiaonan Duan; Zichen Wang; Gabriela Vaz Meirelles; Neil R Clark; Avi Ma'ayan
Journal:  BMC Bioinformatics       Date:  2013-04-15       Impact factor: 3.169

10.  MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling.

Authors:  K Kollmann; J Nangalia; W Warsch; H Quentmeier; A Bench; E Boyd; M Scott; H G Drexler; A R Green
Journal:  Leukemia       Date:  2014-09-24       Impact factor: 11.528
  10 in total
  16 in total

1.  Mutant calreticulin in myeloproliferative neoplasms.

Authors:  Joan How; Gabriela S Hobbs; Ann Mullally
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

2.  JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms.

Authors:  Waihay J Wong; Robert P Hasserjian; Geraldine S Pinkus; Lawrence J Breyfogle; Ann Mullally; Olga Pozdnyakova
Journal:  Haematologica       Date:  2017-11-16       Impact factor: 9.941

Review 3.  Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis.

Authors:  Ross L Levine; Elodie Pronier; Tiffany R Merlinsky
Journal:  Clin Cancer Res       Date:  2019-01-17       Impact factor: 12.531

4.  Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms.

Authors:  William Vainchenker; Isabelle Plo; Mira El-Khoury; Xénia Cabagnols; Matthieu Mosca; Gaëlle Vertenoeil; Christophe Marzac; Fabrizia Favale; Olivier Bluteau; Florence Lorre; Amandine Tisserand; Graciela Rabadan Moraes; Valérie Ugo; Jean-Christophe Ianotto; Jerôme Rey; Eric Solary; Lydia Roy; Philippe Rameau; Najet Debili; Florence Pasquier; Nicole Casadevall; Caroline Marty; Stefan N Constantinescu; Hana Raslova
Journal:  Oncogene       Date:  2020-06-22       Impact factor: 9.867

Review 5.  A rare CALR variant mutation and a review of CALR in essential thrombocythemia.

Authors:  Robert Diep; Ara Metjian
Journal:  J Thromb Thrombolysis       Date:  2018-04       Impact factor: 2.300

Review 6.  Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms.

Authors:  Brandi N Reeves; Joan D Beckman
Journal:  Curr Hematol Malig Rep       Date:  2021-04-19       Impact factor: 4.213

7.  Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus.

Authors:  Francisco Jose Iborra; Petros Papadopoulos
Journal:  Front Oncol       Date:  2017-05-22       Impact factor: 6.244

8.  Proliferation Drives Aging-Related Functional Decline in a Subpopulation of the Hematopoietic Stem Cell Compartment.

Authors:  Kristina Kirschner; Tamir Chandra; Vladimir Kiselev; David Flores-Santa Cruz; Iain C Macaulay; Hyun Jun Park; Juan Li; David G Kent; Rupa Kumar; Dean C Pask; Tina L Hamilton; Martin Hemberg; Wolf Reik; Anthony R Green
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

9.  Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms.

Authors:  Toshinori Kondo; Taizo Tasaka; Nanako Tomioka; Fuminori Sano; Hirotoshi Tokunaga; Shin-Ichiro Suemori; Takayuki Tsujioka; Yoshiko Matsuhashi; Hidekazu Nakanishi; Hideho Wada; Kaoru Tohyama; Takashi Sugihara
Journal:  Springerplus       Date:  2016-07-22

10.  A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.

Authors:  E Calura; S Pizzini; A Bisognin; A Coppe; G Sales; E Gaffo; T Fanelli; C Mannarelli; R Zini; R Norfo; V Pennucci; R Manfredini; C Romualdi; P Guglielmelli; A M Vannucchi; S Bortoluzzi
Journal:  Blood Cancer J       Date:  2016-06-24       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.